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Available online 23 May 2014AbstractBackground/Introduction: Murraya koenigii Linn. (Family: Rutaceae), commonly known as curry patta, is a deciduous shrub found abundantly
throughout India and in other tropical parts of the Asian subcontinent. It is traditionally used for several medicinal and folklore purposes as
astringent, aromatic, demulcent, depurative, anthelmintic, febrifuge, stomachic, appetizing, carminative, anodyne, constipation, anti-inflammatory,
antiseptic, tonic, etc. The leaves are rich in carbazole alkaloids, a class of compounds that are suggested to have stimulating effects on the central
nervous system (CNS).
Purpose/Aim: The study was performed to evaluate the CNS stimulating and analgesic activities of M. koenigii leaves.
Methods: The leaves were extracted with ethanol and phytochemically screened. The CNS stimulating activity was tested by a rat forced swim
test and barbiturate-induced sleeping time model, and the analgesic activity was evaluated by the hot-plate and tail-flick test models.
Results: The yield of leaf extract was 9.75%. The CNS stimulating activities were exhibited by selected doses in both the models; in the rat
forced swim test model, the duration of sleep at 600 mg/kg was significantly (p < 0.01) reduced, that is, 79.56  1.37 seconds as compared with
the control. However, in the barbiturate-induced sleeping time model, the dose of 200 mg/kg was more effective, as onset and duration of sleep
were 1650.16  6.74 seconds and 308.33  5.29 seconds, respectively, which are lower than that observed with standard caffeine
(112.41  2.67 seconds and 1158.47  3.23 seconds, respectively). The average response time at the dose of 600 mg/kg in the hot-plate and tail-
flick models was found to be 11.2  0.04 seconds and 6.77  0.05 seconds (at 120 minutes and 180 minutes), respectively, which is more
prominent than lower dose (300 mg/kg) and comparable with the standard group.
Conclusion: It is evident that ethanol extract of M. koenigii leaves exhibits CNS stimulating and analgesic activities in in vivo models.
Copyright  2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Murraya koenigii Linn. (Family: Rutaceae), commonly
known as curry leaf or curry patta is a deciduous shrub that is
found abundantly throughout India, up to an altitude of 1500 m.* Corresponding author. Pharmacognosy and Ethnopharmacology Division,
Council of Scientific and Industrial Research-National Botanical Research
Institution, Lucknow 226001, Uttar Pradesh, India.
E-mail address: sharad_ks2003@yahoo.com (S. Srivastava).
http://dx.doi.org/10.1016/j.jacme.2014.03.001
2211-5587/Copyright  2014, Taiwan Society of Emergency Medicine. PublishedIt is cultivated in India for its aromatic leaves and as an orna-
mental plant.1 It is also native to other tropical parts of the Asian
subcontinent from Sri Lanka eastward to Myanmar, Indonesia,
Southern China, and Hainan.2 The leaves of the plant contain
proteins, carbohydrates, fibers, minerals, carotene, nicotinic
acid, vitamin C, oxalic acid, crystalline glycosides, carbazole
alkaloids, koenigin, and resin. Fresh leaves contain yellow-
colored volatile oil, and are rich sources of vitamin A and
calcium.3 The leaves also contain various compounds such as
girinimbin, isomahanimbin, koenine, koenigine, koenidine, andby Elsevier Taiwan LLC. All rights reserved.
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losin, coumarine as murrayone imperatoxin.4,5 Triterpenoid
alkaloids such as cyclomahanimbine, tetrahydromahanmbine
and murrayastine, murrayaline, and pypayafoline carbazole
alkaloids are the other chemical compounds reported in the
leaves ofM. koenigii.6,7 The leaves are reported to possess anti-
inflammatory, hepatoprotective, antioxidant, antidiabetic, and
hypolipidemic activities.3e6 Recently, it was also reported that
girinimbine, a carbazole alkaloid isolated from this plant,
inhibited the growth and induced apoptosis in human hepato-
cellular carcinoma cells (HepG2).8
The central nervous system (CNS) stimulants are those
agents whose primary action is to stimulate the whole CNS
(nonspecific) or to improve specific brain function. Such
compounds usually produce a generalized action, which
when administered at higher doses result in convulsions.
These agents are classified into the following three cate-
gories: (1) convulsants (e.g., strychnine, picrotoxin), (2)
analeptic (e.g., doxapram, prethcamide), and (3) psychosti-
mulants (e.g., amphetamine, cocaine, caffeine). The anal-
gesic effect of a drug is mediated through various
mechanisms; primarily, they do not depress CNS, do not
produce physical dependence, and have no abuse liability.
They either act on peripheral pain mechanism or affect the
CNS to increase the threshold.9 At present, depression is a
major concern and is a symptom associated with several
other long lasting diseases such as acquired immunodefi-
ciency syndrome/human immunodeficiency virus, leukemias.
To date, caffeine is the most acceptable and reliable synthetic
for this condition, but this too has the burden of adverse
effects, low response, interactions with cells, etc. By contrast,
drugs obtained from natural resources do not have such
problems of safety and efficacy. Thus, a novel pharmaco-
therapeutic drug with potential effect is the demand of the
hour. Therefore, in this study, we aimed to evaluate the
CNS stimulating and analgesic activities of ethanol extract of
M. koenigii leaves.
2. Methods2.1. Drug and reagentsDiclofenac sodium, pentazocaine, phenobarbitone, caffeine,
diazepam, and imipramine sulfatewere procured commercially.
All the chemicals and reagents (analytical reagent grade) were
purchased from Sigma Aldrich Chemicals Pvt. Ltd. (Bangalore,
India).2.2. Plant materialM. koenigii Linn. leaves were collected from the outskirts
of Lucknow (from a wild area of Ahimamau), Uttar Pradesh,
India, between November 2011 and December 2011. The
sample was authenticated by the Central Instrumentation Fa-
cility, Council of Scientific and Industrial Research-National
Botanical Research Institute (CSIR-NBRI), Lucknow (refer-
ence no. NBRI/CIF/182/2010).2.3. Sample preparationShade-dried leaves (500 g) were coarsely powdered and
subjected to maceration process [after treating with petroleum
ether for 72 hours at room temperature (RT) to remove the
fatty material] in ethanol with intermittent shaking for 7 days
(RT 25  2C). The crude extract thus obtained was filtered,
dried in a rotary evaporator (at the standard condition of
reduced temperature and pressure, i.e., 40C and 40 mbar,
respectively), lyophilized, and quantified. Doses of the extract
were selected based on the results of toxicity study,10 which
showed the toxic effect of the extract at the maximum dose of
5000 mg/kg body weight (bw).
Preliminary phytochemical screening for carbohydrates, pro-
teins, alkaloids, flavonoids, tannins, saponins, steroids, and gly-
cosides, etc.wasperformedaccording to standard procedures.11,122.4. Experimental animalsHealthy adult Wistar albino rats (male/female), weighing
160e190 g, were used for the experimental study of analgesic
activity and swim test of CNS stimulating activity. Swiss al-
bino mice (weight 20e25 g) were used for the barbiturate-
induced sleeping time model.
Animals were housed individually with free access to food
and water under standard conditions of temperature (25 1C)
and humidity (65%  10%). The bw (g) of the animals was
noted regularly.13 All the experimental activities on animals
were performed according to the Organisation for Economic
Co-operation and Development guidelines.2.5. Biological study to evaluate the extract’s CNS
stimulating activity
2.5.1. Rat forced swim test
Animals were divided into five groups (6 rats/group).
Groups A, B, and C received the ethanolic extract in normal
saline, per os (p.o.) at 50 mg/kg bw, 100 mg/kg bw, and
200 mg/kg bw doses, respectively. Group D received normal
saline (1 mL/kg bw, p.o.) and served as the control group,
Group E received imipramine HCl (30 mg/kg bw, p.o.). Test
and standard drugs were administered 1 hour prior to testing.
The rats were individually forced to swim inside a vertical
PLEXIGLAS cylinder (height: 40 cm; diameter: 18 cm, con-
taining 20 cm of water maintained at 25C). Rats placed in the
cylinders for the first time are initially highly active, vigor-
ously swimming in circles, trying to climb the wall or diving
to the bottom. After 2e3 minutes, their activity begins to
subside and to be interspersed with phases of immobility or
floating of increasing length. After 5e6 minutes, immobility
reaches a plateau, and the rats remain immobile for approxi-
mately 80% of the time. After 15 minutes in the water, the rats
were removed and allowed to dry in a heated enclosure (32C)
prior to being returned to their home cages. The animals were
again placed in the cylinder 24 hours later and the total
duration of immobility was measured during a 5-minute test.
The floating behavior during this 5-minute period has been
Table 1
Duration of immobility of experimental animals in the rat forced swim test
model.
S. no Treatment Duration of immobility (s)
1 Control (1 mL/kg) 187.42  5.19
2 MK (300 mg/kg) 108.07  4.15*
3 MK (600 mg/kg) 79.56  1.37*
4 Imipramine (15 mg/kg) 93.34  2.19*
Data are presented as the mean  standard error of the mean (n ¼ 6).
*p < 0.01 shows a significant difference from the control (Dunnett’s test).
MK ¼ Murraya koenigii.
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is judged to be immobile whenever it floats passively in the
water in a slightly hunched but upright position, with its nose
just above the surface.14
2.5.2. Barbiturate-induced sleeping time test
Animals were divided into six groups (6 mice/group).
Groups A, B, and C received ethanol extract in normal saline
p.o. at 50 mg/kg, 100 mg/kg, and 200 mg/kg doses, respec-
tively. Group D received normal saline (1 mL/kg, p.o.) and
served as the control group, Groups E and F received caffeine
(20 mg/kg, p.o.) and diazepam (0.1 mg/kg, p.o.) and served as
the standard group. All treatments were done 60 minutes prior
to the oral administration of phenobarbitone (40 mg/kg, p.o.).
The time elapsed between the administration of phenobarbitone
and the loss of the righting reflex was recorded as sleep latency,
and the time elapsed between loss and voluntary recovery of the
righting reflex is recorded as sleeping time. The onset of sleep
and duration of sleeping time for each animal was determined
and the mean for each group was calculated.9,15,162.6. Biological study for analgesic activity
2.6.1. Hot-plate test
A hot plate was used to measure response latencies ac-
cording to the method described previously.13 The rats were
placed on an Ugo Basile hot plate maintained at 55C and time
between placement of the mouse on the platform and shaking
or licking of the paws or jumping was recorded as the hot-
plate latency. Rats with baseline latencies higher than 10 sec-
onds were eliminated from the study. Twenty-four hours later,
the animals were treated with an ethanol extract of M. koenigii
(300 mg/kg and 600 mg/kg, p.o.) or with diclofenac sodium
(25 mg/kg, p.o.) 60 minutes prior to the test. The control
animals received the same volume of vehicle solution (2% w/v
acacia gum, p.o.). After administration of the drugs, the
reaction time was measured at 0 minutes, 30 minutes, 60 mi-
nutes, and 120 minutes.
2.6.2. Tail-flick test
Prior to performing analgesic experiments, the animals
were screened for the sensitivity test by immersing the tail of
the rats gently in hot water maintained at 55e55.5C. The
animal immersing its tail in hot water within 5 seconds was
selected for the study. Selected rats were then divided into four
groups of six rats each. Group I and Group II received 2% w/v
of acacia gum in normal saline and pentazocine (30 mg/kg,
p.o.), respectively. Group III and Group IV received the extract
(2% w/v acacia gum p.o.) at a dose of 300 mg/kg bw and
600 mg/kg bw, respectively. After administration of the drugs,
the reaction time was measured at 0 minutes, 30 minutes,
60 minutes, 120 minutes, and 180 minutes.132.7. Statistical analysis
Fig. 1. Delay in onset of sleep (in seconds) exhibited by Murraya koenigii
(MK) leaves extract at different concentrations (50 mg/kg, 100 mg/kg, and
200 mg/kg) was found to be statistically significantly different from control at
p < 0.01 in the barbiturate-induced sleeping time model.Results obtained from the study were expressed as
mean  standard error of the mean and data were analyzedusing one-way analysis of variance followed by Dunnett’s test.
Results were considered significant when p < 0.01.
3. Results
The yield of M. koenigii leaf extract in ethanol was 9.75%,
which had the characteristic, pleasant, and acceptable odor.
Preliminary phytochemical screening reveals the presence of
alkaloids, carbohydrates, flavonoids, proteins, and amino acids
in the extract. However, glycoside, fixed oil, tannins, steroids,
and triterpenoids were altogether absent.
The CNS stimulating activity was determined using the rat
forced swim test (300 mg/kg bw and 600 mg/kg bw) and
barbiturate-induced sleeping time test (at 50 mg/kg bw,
100 mg/kg bw, and 150 mg/kg bw) in rats and mice, respec-
tively. In the rat forced swim test model, the extract showed
significant activity (p < 0.01) at both the doses (Table 1);
however, the activity was more promising at 600 mg/kg, that
is, the duration of inhibition was 79.56 seconds and is com-
parable with standard imipramine (93.34  2.19 seconds). In
the barbiturate-induced sleeping time model (Fig. 1), the
extract caused significant delay in onset of sleep at the tested
doses and is found to be significant (p < 0.01) when compared
with control. Results were promising at 50 mg/kg and 100 mg/
kg doses when compared with the standard group, but the
effectiveness of extract at 200 mg/kg dose was even better than
Fig. 2. Sleeping duration exhibited byMurraya koenigii (MK) leaves extract at
50 mg/kg, 100 mg/kg, and 200 mg/kg was found to be statistically signifi-
cantly different from control at p < 0.01 in the barbiturate-induced sleeping
time model.
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doses, reduction in duration of the sleeping time was
maximum at 200 mg/kg, followed by 100 mg/kg and 50 mg/kg
(i.e., 308.33  5.29 seconds, 833.33  5.29 seconds, and
1126.16  4.48 seconds, respectively). The extract at higher
dose (200 mg/kg) was effective than standard (caffeine at
20 mg/kg), indicating better CNS stimulating action (Fig. 2).
Analgesic screening was done experimentally by the hot-
plate and tail-flick models in rats. Ethanol extract was
administered orally at the doses of 300 mg/kg and 600 mg/kg
(Tables 2 and 3), and the results were found to be significant at
p < 0.01 when compared with control. The activity potential
increases in a dose-dependent manner along with time.Table 3
Average response time of Murraya koenigii leaves extract and standard in tail-flic




1 Control (1 mL/kg) 2.5  0.33 2.8  0
2 MK (300 mg/kg) 2.72  0.24 2.91  0
3 MK (600 mg/kg) 3.49  0.02 3.69  0
4 Pentazocine (30 mg/kg) 2.40  0.25 3.90  0
Data are presented as the mean  standard error of the mean (n ¼ 6).
*p < 0.01 shows significant difference from control (Dunnett’s test).
MK ¼ Murraya koenigii.
Table 2
Average response time (in minutes) of Murraya koenigii leaves extract and standa
S. no Treatment Response time at 0 min Response ti
1 Control (1 mL/kg) 3.25  0.05 4.83
2 MK (300 mg/kg) 3.57  0.17 7.72
3 MK (600 mg/kg) 3.39  0.02 8.22
4 Diclofenac (25 mg/kg) 3.35  0.40 10.03
Data are presented as the mean  standard error of the mean (n ¼ 6).
*p < 0.01 shows significant difference from control (Dunnett’s test).
MK ¼ Murraya koenigii.4. Discussion
In the forced swim test model for assessment of CNS
stimulating activity, mice are forced to swim in a limited
space; they quickly abandon swimming and stand still.
Although all antidepressant drugs reduce immobility in the
forced swim test (FST) two distinct active behavioral patterns
are produced by pharmacologically selective antidepressant
drugs. Antidepressants that selectively inhibit norepinephrine
uptake reduce the immobility and selectively increase climb-
ing without affecting swimming. By contrast, serotonin reup-
take inhibitor also reduces immobility but increases swimming
instead of climbing.
The precise mechanisms by which M. koenigii leaves
extract produced an antidepressant-like effect are not
completely understood. However, according to our results, the
pattern of behaviors exerted by the extract in the FST is similar
to those of imipramine, suggesting that the plant extract
probably acts by enhancing norepinephrine neurotransmis-
sion.17 Present studies showed that the extract of Murraya was
effective in producing significant antidepressant effect in mice,
which may be due to presence of high level of carbazole al-
kaloids. As this is the first ever report on the CNS stimulating
activity of Murraya leaves, ethanol (intermediately polar) was
selected as the solvent because of its property to extract a wide
range of phytochemicals. Thus, the plant species can be used
effectively in the treatment of CNS disorder. Medicinal plants
with potential therapeutic activity in CNS disorders are highly
suggestive due to their safety, efficacy, and acceptability. A
rapid tolerance is developed with caffeine against its stimu-
lating effect and thus mild withdrawal symptoms emerge, and
this is one of the major concerns associated with caffeine.
Although several other synthetics are also used clinically, they









.21 2.90  0.21 3.1  0.19 2.60  0.15
.12 3.12  0.09 4.78  0.02* 5.52  0.04*
.04 4.86  0.04* 5.89  0.17* 6.77  0.05*
.33* 5.0  0.23* 6.20  0.43* 7.60  0.56*
rd in the hot-plate model.
me at 30 min Response time at 60 min Response time at 120 min
 0.10 5.83  0.11 7.12  0.05
 0.13* 8.22  0.02* 8.76  0.07*
 0.02* 9.4  0.07* 11.2  0.04*
 0.12* 11.39  0.53* 13.15  0.38*
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with ethanol was also evaluated, although there are some
studies on the analgesic activity ofM. koenigii leaves extracted
with methanol18; however, to eliminate the solvent effect,
ethanol is used as an alternative in this study. The analgesic
effect was, however, increased gradually with respect to dose,
that is, response time to the cause was more at the higher dose
in both models. The mechanism of action, however, seems to be
similar to that of standard drugs, and further study is required to
identify the real mechanism of action in a more precise manner.
Thus, it is evident that the extract exhibits CNS stimulating and
analgesic activities in a promising way, but as the underlying
mechanism of action is still not clearly understood, the study
needs to be elaborated further on fraction-guided isolation of
metabolites and activity testing, thereof in particular.
The study hence supported that in vivo modeling for CNS
stimulating and analgesic activities of M. koenigii Linn. leaves
(ethanol extract) produces significant effects on experimental
animals in a dose-dependent manner and can serve as better
alternatives for psychotic/associated illnesses along with po-
tential analgesic activity.
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